GLD News 125.20 07/30/2014 05:09:27 SPDR Gold (GLD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
SPDR Gold (GLD) 125.20 $GLD

Will Gold Prices Keep Losing Ground as Fed Meeting Looms?
at The Street - Fri Jul 25, 11:46AM CDT
What could keep dragging down the price of gold?

Where to Invest: Metals and Miners Are Weak; U.S. Stocks, Dollar Outperform
at The Street - Fri Jul 25, 10:33AM CDT
Gold and gold miners have experienced selling pressure recently but the U.S. dollar and equities have outperformed expectations.

SmarTrend Watching for Potential Rebound in Shares of SPDR Gold Trust After 1.01% Loss
Comtex SmarTrend(R) - Thu Jul 24, 3:39PM CDT
SPDR Gold Trust (NYSE:GLD) traded in a range yesterday that spanned from a low of $123.90 to a high of $124.87. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $125.40 on volume of 8.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Has Gold Lost its Safe Haven Appeal? - Real Time Insight
Neena Mishra - Zacks Investment Research - Thu Jul 24, 2:24PM CDT
Gold prices are down over the past few weeks even though geopolitical tensions have been rising.

Safe Haven ETFs to Evade Geopolitical Tensions - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jul 22, 2:00PM CDT
The uncertainty in Ukraine and the Middle East compelled investors to shift their focus to safe haven ETF plays.

Russian Sanctions and Malaysian Plane Crash Put These ETFs in Focus - ETF News And Commentary
Eric Dutram - ZACKS - Thu Jul 17, 5:15PM CDT
With the crash of Malaysian Airlines flight 17, investors scrambled to safe assets and ETFs.

Markets Go From Wednesday's High to Getting Smashed Today
at The Street - Thu Jul 17, 4:40PM CDT
The stock indexes saw huge selling on Thursday with increased downside volume.

Gold Spikes as Plane Crash Stokes Speculation of Escalation in Ukraine Tensions
at The Street - Thu Jul 17, 11:06AM CDT
Gold prices surge as reports emerge of rebels shooting down a passenger plane in Ukraine.

When Will the Bull Market End? Keep Your Eye on the Small-Caps
at The Street - Thu Jul 17, 5:30AM CDT
A lot of risk came off the table last week as investors reacted to a multitude of geopolitical events.

Janet Yellen Gets Market's Volume Moving to the Downside
at The Street - Tue Jul 15, 4:23PM CDT
The stock indexes finished lower Tuesday with a huge increase in trading volume.

S&P 500 Choppy Stock Action Not Worth Trading, So Take Some Time Off
at The Street - Tue Jul 15, 3:43PM CDT
We���ve had some poor days this summer, but today has to take the cake.

Gold Tumbles Down ��� Has the Rally Ended?
at The Street - Tue Jul 15, 11:17AM CDT
The price of gold has changed direction. Will the fall continue?

Market Closes Higher Ahead of Yellen's Congressional Testimony
at The Street - Mon Jul 14, 4:23PM CDT
The four major stock indices closed higher but trading volume was among the lowest of the year.

Stock Pickers' Market Coming Off Oversold Reading for S&P 500
at The Street - Mon Jul 14, 3:51PM CDT
We are coming off oversold levels, so who know if this is a bounce or something more sustainable.

Look for Shares of SPDR Gold Trust to Potentially Rebound after Yesterday's 2.38% Sell Off
Comtex SmarTrend(R) - Mon Jul 14, 3:41PM CDT
SPDR Gold Trust (NYSE:GLD) traded in a range yesterday that spanned from a low of $125.45 to a high of $126.10. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $127.18 on volume of 11.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of SPDR Gold Trust After 2.38% Loss
Comtex SmarTrend(R) - Mon Jul 14, 3:41PM CDT
SPDR Gold Trust (NYSE:GLD) traded in a range yesterday that spanned from a low of $125.45 to a high of $126.10. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $127.18 on volume of 11.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading